Skip to main content

Table 1 Demographics (mean ± SD unless otherwise stated).

From: Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance

Total number of patients

45

Age (years)

27.1 ± 9.6

Sex

 

Male

19

Female

26

Race/ethnicity

 

White

19

South Asian

13

Arabic

8

African

5

Units of blood transfused (units/year)

32.2 ± 17.3

Past history cardiac disease

 

Heart Failure

5 (11%)

Time between heart failure and scan (years)

3.7 ± 7.6

Arrhythmia

4 (9%)

Time between arrhythmia and scan (years)

4.0 ± 6.7

CMR measures:

 

Cardiac T2* (ms) median (Q1, Q3)

22.6 (13.4, 34.5)

Liver T2* (ms) median (Q1, Q3)

4.4 (2.3, 8.5)

LV end diastolic volume (mL)

134 ± 41.4

LV end systolic volume (mL)

46.4 ± 20.2

LV ejection fraction (%)

65.8 ± 8.5

Chelation

 

Deferoxamine only

21 (47%)

Deferiprone only

3 (7%)

Deferasirox only

9 (20%)

Deferoxamine & deferiprone

11 (24%)

No Chelation

1 (2%)